Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
Relay Therapeutics (NASDAQ: RLAY), a clinical-stage precision medicine company, has announced its participation in two major investor conferences in June 2025. The company's management will engage in fireside chats at the Jefferies Global Healthcare Conference on June 4 at 8:45 a.m. ET and the Goldman Sachs Global Healthcare Conference on June 11 at 2:40 p.m. ET. Both presentations will be accessible via live webcast through Relay's website, with recordings available for 30 days after each event.
Relay Therapeutics (NASDAQ: RLAY), un'azienda di medicina di precisione in fase clinica, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. Il management dell'azienda prenderà parte a incontri informali al Jefferies Global Healthcare Conference il 4 giugno alle 8:45 ET e al Goldman Sachs Global Healthcare Conference l'11 giugno alle 14:40 ET. Entrambe le presentazioni saranno disponibili in diretta streaming sul sito di Relay, con le registrazioni accessibili per 30 giorni dopo ogni evento.
Relay Therapeutics (NASDAQ: RLAY), una empresa de medicina de precisión en etapa clínica, ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La dirección de la compañía participará en charlas informales en la Jefferies Global Healthcare Conference el 4 de junio a las 8:45 a.m. ET y en la Goldman Sachs Global Healthcare Conference el 11 de junio a las 2:40 p.m. ET. Ambas presentaciones estarán disponibles vía webcast en vivo a través del sitio web de Relay, con grabaciones accesibles durante 30 días después de cada evento.
Relay Therapeutics (NASDAQ: RLAY)는 임상 단계 정밀 의료 회사로서 2025년 6월에 개최되는 두 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 6월 4일 오전 8시 45분(동부시간)에 열리는 Jefferies Global Healthcare Conference와 6월 11일 오후 2시 40분(동부시간)에 열리는 Goldman Sachs Global Healthcare Conference에서 파이어사이드 채팅에 참여할 예정입니다. 두 발표 모두 Relay 웹사이트를 통해 라이브 웹캐스트로 시청 가능하며, 각 행사 후 30일 동안 녹화본을 볼 수 있습니다.
Relay Therapeutics (NASDAQ : RLAY), une société de médecine de précision en phase clinique, a annoncé sa participation à deux grandes conférences investisseurs en juin 2025. La direction de l'entreprise prendra part à des discussions informelles lors de la Jefferies Global Healthcare Conference le 4 juin à 8h45 ET et lors de la Goldman Sachs Global Healthcare Conference le 11 juin à 14h40 ET. Les deux présentations seront accessibles en webcast en direct via le site web de Relay, avec des enregistrements disponibles pendant 30 jours après chaque événement.
Relay Therapeutics (NASDAQ: RLAY), ein klinisch tätiges Präzisionsmedizinunternehmen, hat seine Teilnahme an zwei großen Investorenkonferenzen im Juni 2025 angekündigt. Das Management des Unternehmens wird am Jefferies Global Healthcare Conference am 4. Juni um 8:45 Uhr ET und am Goldman Sachs Global Healthcare Conference am 11. Juni um 14:40 Uhr ET in Fireside-Chats teilnehmen. Beide Präsentationen sind über einen Live-Webcast auf der Website von Relay zugänglich, mit Aufzeichnungen, die 30 Tage nach jeder Veranstaltung verfügbar sind.
- None.
- None.
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in two upcoming fireside chats in June:
- Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 8:45 a.m. ET
- Goldman Sachs Global Healthcare Conference on Wednesday, June 11, 2025 at 2:40 p.m. ET
The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo® platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.
Contact:
Pete Rahmer
prahmer@relaytx.com
Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com
FAQ
When is Relay Therapeutics (RLAY) presenting at the Jefferies Healthcare Conference 2025?
What time is RLAY's presentation at the Goldman Sachs Healthcare Conference 2025?
How long will Relay Therapeutics' conference webcasts be available for replay?
Where can I access Relay Therapeutics' (RLAY) conference presentations?
